Apogee Therapeutics, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Apogee Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $1.22M, a 53.27% increase year-over-year.
- Apogee Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $796.00K, a 111.14% increase year-over-year.
- Apogee Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $377.00K.
- Apogee Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.56M, a 101.03% increase from fiscal 2024.
- Apogee Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $774.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $1.22M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $1.56M 10-K · filed 2026-03-02 | |
| 2025-06-30 | $796.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $774.00K 10-K · filed 2026-03-02 | |
| 2024-06-30 | $377.00K 10-Q · filed 2025-11-10 |